EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Korkmaz, A.
Right arrow Articles by Öter, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korkmaz, A.
Right arrow Articles by Öter, S.
Experimental Biology and Medicine 233:338-343 (2008)
doi: 10.3181/0706-RM-151
© 2008 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Effects of Poly(ADP-Ribose) Polymerase Inhibition in Bladder Damage Caused by Cyclophosphamide in Rats

Ahmet Korkmaz*, Bülent Kurt{dagger}, Ibrahim Yildirim{ddagger}, Seref Basal{ddagger}, Turgut Topal*, Serdar Sadir* and Sükrü Öter*,1

* Department of Physiology, {dagger} Department of Pathology, and {ddagger} Department of Urology, Gulhane Military Medical Academy, 06018, Ankara, Turkey

To whom requests for reprints should be addressed at 1 Gulhane Askeri Tip Akademisi, Fizyoloji Anabilim Dali, 06018 – Etlik, Ankara, Turkey. E-mail: oters{at}gata.edu.tr; fizyoter{at}gmail.com

It was previously shown that nitric oxide produced by inducible nitric oxide synthase (iNOS) and peroxynitrite are responsible for cyclophosphamide (CP)-induced cystitis. Since endogenous production of peroxynitrite is known to lead to poly(ADP-ribose) polymerase (PARP) activation, in this study, the aim was to evaluate whether the PARP activation pathway is also included in the pathogenesis of CP-induced bladder ulceration in rats. A total of 48 male albino Wistar rats were divided into 5 groups. Group 1 served as control and was given 2 ml saline; four groups received a single dose of CP (200 mg/kg) with the same time intervals. Group 2 received CP only; Group 3, selective iNOS inhibitor 1400W (20 mg/kg); Group 4, peroxynitrite scavenger ebselen (30 mg/kg); and Group 5, PARP inhibitor 3-aminobenzamide (20 mg/kg). CP injection resulted in severe cystitis with continuous macroscopic hemorrhage, strong edema, inflammation, and ulceration. Moreover, bladder iNOS activation and urine nitrite-nitrate levels were dramatically increased. Histologically, 1400W protected bladder against CP damage and decreased urine nitrite-nitrate levels and bladder iNOS induction. Ebselen has shown similar histologic results with 1400W without changing urinary nitrite-nitrate level and iNOS activity. Furthermore in the 3-aminobenzamide group, beneficial effects had also occurred including decreased ulceration. These results suggest that PARP activation involves pathogenesis of CP-induced bladder ulceration. Furthermore, PARP is not only important for ulceration but also for bladder edema, hemorrhage, and inflammation because of broken uroepithelial cellular integrity.

Key Words: cyclophosphamide • hemorrhagic cystitis • nitric oxide • peroxynitrite • poly(ADP-ribose) polymerase







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Experimental Biology and Medicine.